Inventor · Columbus, OH, US

John C. Byrd

17Patents

7h-index

46Co-inventors

66Inventor score

Filing activity: Feb 24, 1999 → Nov 10, 2021

Most-cited inventions

Patent	Title	Area	Cited by	Status
US8119101B2	Anti-CD74 immunoconjugates and methods of use	Physics	87	Active
US9795604B2	Methods of treating and preventing graft versus host disease	Human Necessities	12	Active
US6841565B1	Treatment of patients with chronic lymphocytic leukemia	Human Necessities	12	Expired
US6316435A	Combination therapy for lymphoproliferative diseases	Human Necessities	10	Expired
US9717731B2	TEC family kinase inhibitor adjuvant therapy	Human Necessities	9	Active
US9885086B2	Phospholipase C gamma 2 and resistance associated mutations	Physics	8	Active
US10357514B2	Treatment of cancer using anti-CD19 Chimeric Antigen Receptor	Chemistry; Metallurgy	7	Active
US8846002B2	Anti-CD74 immunoconjugates and methods of use	Physics	5	Active
US8309768B2	FTY720-derived anticancer agents	Chemistry; Metallurgy	5	Active
US10463668B2	Methods of treating and preventing graft versus host disease	Human Necessities	2	Active
US10695350B2	Methods of treating and preventing graft versus host disease	Human Necessities	1	Active
US8367037B2	Anti-CD74 immunoconjugates and methods of use	Physics	1	Active
US8633161B2	Therapeutic agents for the treatment of leukemia	Physics	1	Active
US9044474B2	Compositions and methods for increasing drug efficacy in cancer	Physics	1	Active
US11312686B2	Methods and compositions for inhibition of dihydroorotate dehydrogenase	Human Necessities	0	Active
US8318812B2	Therapeutic agents for the treatment of lymphoid malignancies	Human Necessities	0	Active
US11999697B2	Methods and compositions for inhibition of dihydroorotate dehydrogenase	Human Necessities	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.